BioSpace

BMS reports liver injury events in lung disease program, with key readout near

Bristol Myers Squibb will soon release Phase 3 data for admilparant that could make or break Contineum Therapeutics’ rival product. But reports of a death due to liver injury in the pharma’s program have caused some unease about the drug class.

作者 BioSpace

1 分钟阅读
BMS reports liver injury events in lung disease program, with key readout near
BMS reports liver injury events in lung disease program, with key readout near

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察